Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
<Group xmlns="http://hl7.org/fhir">
<id value="438155"/>
<meta>
<versionId value="25"/>
<lastUpdated value="2026-07-23T13:49:34.467Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/study-eligibility-criteria"/>
</meta>
<language value="en"/>
<text>
<status value="empty"/>
<div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><p>[No data.]</p></div>
</text>
<extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
<valueMarkdown
value="CTIS2025-523977-40-00 Eligibility Criteria - ARMYDA Study on Coronary Plaque Change with Semaglutide in Diabetes with ACS [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 438155. Revised 2026-07-23. Available at: https://fevir.net/resources/Group/438155. Computable resource at: https://fevir.net/resources/Group/438155#json."/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Brian S. Alper, MD, MSPH"/>
</valueContactDetail>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="derived-from"/>
<resourceReference>
<reference value="Group/438152"/>
<type value="Group"/>
<display value="CTIS2025-523977-40-00 Eligibility Criteria"/>
</resourceReference>
</valueRelatedArtifact>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="supports"/>
<resourceReference>
<reference value="ResearchStudy/438151"/>
<type value="ResearchStudy"/>
<display
value="Changes in Coronary Plaque Composition By Semaglutide Use in Diabetic Patients With Acute Coronary Syndrome: A Randomized Optical Coherence Tomography Trial - ARMYDA - 10 study"/>
</resourceReference>
</valueRelatedArtifact>
</extension>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/Group/438155"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="438155"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name value="ARMYDA_Eligibility_Criteria"/>
<title
value="CTIS2025-523977-40-00 Eligibility Criteria - ARMYDA Study on Coronary Plaque Change with Semaglutide in Diabetes with ACS"/>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<type value="person"/>
<membership value="definitional"/>
<combinationMethod value="all-of"/>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="44054006"/>
<display value="Diabetes mellitus type 2 (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="false"/>
<description value="Diagnosis of T2DM"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="401314000"/>
<display
value="Acute non-ST segment elevation myocardial infarction (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="false"/>
<description value="Non-ST-segment elevation ACS"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Presence of one identifiable culprit coronary lesion treated with percutaneous coronary intervention (PCI)"/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Presence of one identifiable culprit coronary lesion treated with percutaneous coronary intervention (PCI)"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Presence of at least one non-culprit, mild to intermediate stenosis (30% to 69% lumen narrowing) at coronary angiography, with a macrophage arc detectable on optical coherence tomography (OCT), on a major epicardial coronary artery different from the culprit vessel"/>
</valueCodeableConcept>
<exclude value="false"/>
<description
value="Presence of at least one non-culprit, mild to intermediate stenosis (30% to 69% lumen narrowing) at coronary angiography, with a macrophage arc detectable on optical coherence tomography (OCT), on a major epicardial coronary artery different from the culprit vessel"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="397669002"/>
<display value="Age"/>
</coding>
</code>
<valueQuantity>
<value value="40"/>
<comparator value=">="/>
<unit value="years"/>
<system value="http://unitsofmeasure.org"/>
<code value="a"/>
</valueQuantity>
<exclude value="false"/>
<description value="Age ≥40 years"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Signed informed consent."/>
</valueCodeableConcept>
<exclude value="false"/>
<description value="Signed informed consent."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="10633002"/>
<display value="Acute congestive heart failure (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Acute heart failure"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
</coding>
<text value="Estimated glomerular filtration rate"/>
</code>
<valueQuantity>
<value value="30"/>
<comparator value="<"/>
<unit value="mL/min/1.73 m²"/>
</valueQuantity>
<exclude value="true"/>
<description
value="Renal dysfunction (estimated GFR <30 mL/min/1.73 m²)"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="71388002"/>
<display value="Procedure (procedure)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="108241001"/>
<display value="Dialysis procedure (Procedure)"/>
</coding>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Renal dysfunction (on dialysis)"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="75694006"/>
<display value="Pancreatitis (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="true"/>
<description value="History of pancreatitis."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="High risk of pancreatitis."/>
</valueCodeableConcept>
<exclude value="true"/>
<description value="High risk of pancreatitis."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Severe gastroparesis requiring therapy <6 months prior to randomization."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Severe gastroparesis requiring therapy <6 months prior to randomization."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Active malignancy or history of neuroendocrine tumors."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Active malignancy or history of neuroendocrine tumors."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Hypersensitivity or contraindications to semaglutide or its excipients."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Hypersensitivity or contraindications to semaglutide or its excipients."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="76625-3"/>
<display
value="Alanine aminotransferase [Enzymatic activity/volume] in Blood"/>
</coding>
</code>
<valueQuantity>
<value value="2"/>
<comparator value=">"/>
<unit value="upper limit of normal"/>
<system value="http://hl7.org/fhir/characteristic-offset"/>
<code value="UNL"/>
</valueQuantity>
<exclude value="true"/>
<description
value="Severe hepatic dysfunction (ALT >2× upper limit of normal)."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="1920-8"/>
<display
value="Aspartate aminotransferase [Enzymatic activity/volume] in Blood"/>
</coding>
</code>
<valueQuantity>
<value value="2"/>
<comparator value=">"/>
<unit value="upper limit of normal"/>
<system value="http://hl7.org/fhir/characteristic-offset"/>
<code value="UNL"/>
</valueQuantity>
<exclude value="true"/>
<description
value="Severe hepatic dysfunction (AST >2× upper limit of normal)."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="1975-2"/>
<display
value="Total Bilirubin in Serum or Plasma (measured by mass/volume, e.g., mg/dL)"/>
</coding>
</code>
<valueQuantity>
<value value="1.5"/>
<comparator value=">"/>
<unit value="upper limit of normal"/>
<system value="http://hl7.org/fhir/characteristic-offset"/>
<code value="UNL"/>
</valueQuantity>
<exclude value="true"/>
<description
value="Severe hepatic dysfunction (total bilirubin >1.5× upper limit of normal)."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text
value="Pregnancy or breastfeeding. Women of childbearing potential must have a negative pregnancy test at screening and agree to use effective contraception during the study."/>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Pregnancy or breastfeeding. Women of childbearing potential must have a negative pregnancy test at screening and agree to use effective contraception during the study."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="420422005"/>
<display value="Ketoacidosis due to diabetes mellitus (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Patients with diabetic ketoacidosis"/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="true"/>
</extension>
<code>
<coding>
<system value="http://hl7.org/fhir/fhir-types"/>
<code value="MedicationRequest"/>
<display value="MedicationRequest"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1991302"/>
<display value="semaglutide"/>
</coding>
</valueCodeableConcept>
<exclude value="true"/>
<description
value="Use of semaglutide at screening within 30 days prior to randomization."/>
</characteristic>
<characteristic>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching">
<valueBoolean value="false"/>
</extension>
<code>
<text value="Defined by CodeableConcept"/>
</code>
<valueCodeableConcept>
<text value="Inability to provide informed consent."/>
</valueCodeableConcept>
<exclude value="true"/>
<description value="Inability to provide informed consent."/>
</characteristic>
</Group>